文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

成人高钙危象的管理:肾脏替代治疗的当前作用

Management of hypercalcaemic crisis in adults: Current role of renal replacement therapy.
PubMed 文献 · Am J Emerg Med · 2018-03-07
一句话结论高钙危象以肿瘤为主要病因,低钙透析液肾脏替代治疗可安全用于纠正高钙血症及相关急性肾损伤。

该回顾性研究在摩洛哥东部Oujda大学医院肾内科进行,为期36个月,纳入12例成人高钙危象患者(校正总血钙>3.5mmol/l),全部为女性,9例病因为肿瘤。所有患者接受静脉补液、糖皮质激素和双膦酸盐治疗,11例使用低钙透析液行肾脏替代治疗。3例在住院24小时内死亡。作者结论认为肾脏替代治疗应作为高钙危象的一线治疗充分发挥作用,低钙或无钙透析液可安全处方。

要点

  • 高钙危象定义为校正总血钙>3.5mmol/l,肿瘤是最主要病因(12例中9例)。
  • 11例患者使用低钙透析液行肾脏替代治疗,用于纠正高钙血症、尿毒症及急性肾损伤相关电解质紊乱。
  • 8例出现心电图异常,8例合并急性肾损伤,3例为慢性肾脏病血液透析患者。
  • 3例在住院24小时内死亡,提示高钙危象早期死亡率高。
  • 作者认为肾脏替代治疗应作为高钙危象的一线治疗,低钙或无钙透析液安全可行。

适用人群与场景

  • 成人高钙危象患者,定义为校正总血钙>3.5mmol/l。
  • 研究在摩洛哥东部Oujda大学医院肾内科进行,纳入36个月期间诊断的成人患者。

诊断标准与关键阈值

  • 高钙危象诊断标准:校正总血钙>3.5mmol/l。

处置流程与药物剂量

  • 所有患者接受静脉补液、糖皮质激素和双膦酸盐治疗。
  • 11例患者使用低钙透析液行肾脏替代治疗。

红旗征与不能漏的情况

  • 心电图异常见于8例。
  • 急性肾损伤见于8例。
  • 3例在住院24小时内死亡。

研究设计与关键结果

  • 回顾性研究,36个月,纳入12例成人高钙危象患者,全部为女性,5例为老年人(≥65岁)。
  • 3例血清钙>4mmol/l,最高钙值为5.8mmol/l。
  • 心电图异常8例,急性肾损伤8例,慢性肾脏病血液透析3例,肿瘤9例。
  • 所有患者接受静脉补液、糖皮质激素和双膦酸盐治疗;11例使用低钙透析液行肾脏替代治疗。
  • 3例在住院24小时内死亡。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为肾脏替代治疗应作为高钙危象的一线治疗充分发挥作用。
  • 作者认为随着血液透析技术改进及低钙或无钙透析液的使用,该治疗可安全处方,获益-风险比为正向。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Neoplasms and hematologic diseases are the predominant etiologies of hypercalcemic crisis in adults and the immediate treatment is mainly medical and symptomatic. The use of renal replacement therapy (RRT) is often necessary to correct the hypercalcemia, uremia and electrolyte disturbances related to Acute Kidney Injury (AKI). The aim of this work was to determine the etiologies and the place of RRT in treating patients with hypercalcaemic crisis. We conducted a retrospective study for 36months at the Nephrology Unit, University Hospital, Oujda, eastern of Morocco. We included all adult patients diagnosed with hypercalcemic crisis that was defined as corrected total serum calcium of >3.5mmol/l.

RESULTS: 12 patients were collected. All patients were female and 5 patients were elderly (≥65years). Three patients had a serum calcium value of >4mmol/l and the highest calcium value was 5.8mmol/l. Electrocardiographic abnormalities were observed in 8 cases. AKI was observed in 8 cases. Three patients had chronic kidney disease on hemodialysis. Neoplasm was noted in 9 cases. All patients received venous rehydration, glucocorticoids and biphosphonates. The use of RRT with low calcium dialysate was performed in 11 cases. Three patients died during the first 24h of hospitalization.

CONCLUSION: RRT must play its full role as first line treatment of hypercalcemia crisis. Improvements in hemodialysis techniques and the use of low calcium or calcium-free dialysates currently allows this therapeutic measure to be prescribed safely, and the benefit-risk balance is positive for the great benefit provided by dialysis.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Bentata Y, El Maghraoui H, Benabdelhak M, et al. Management of hypercalcaemic crisis in adults: Current role of renal replacement therapy. Am J Emerg Med. 2018. PMID: 29631925. doi:10.1016/j.ajem.2018.03.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。